dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
dc.contributor.author | Grenader, Tal |
dc.contributor.author | Pavel, Marianne E. |
dc.contributor.author | Ruszniewski, Philippe B. |
dc.contributor.author | Ćwikła, Jarosław B. |
dc.contributor.author | Phan, Alexandria T. |
dc.contributor.author | Raderer, Markus |
dc.contributor.author | Capdevila Castillon, Jaume |
dc.date.accessioned | 2021-10-29T07:38:42Z |
dc.date.available | 2021-10-29T07:38:42Z |
dc.date.issued | 2020-03 |
dc.identifier.citation | Grenader T, Pavel ME, Ruszniewski PB, Ćwikła JB, Phan AT, Raderer M, et al. Prognostic value of the neutrophil/lymphocyte ratio in enteropancreatic neuroendocrine tumors. Anticancer Drugs. 2020 Mar;31(3):216–22. |
dc.identifier.issn | 0959-4973 |
dc.identifier.uri | https://hdl.handle.net/11351/6483 |
dc.description | Supervivencia libre de progresión; Tumores neuroendocrinos |
dc.language.iso | eng |
dc.publisher | Wolters Kluwer Health |
dc.relation.ispartofseries | Anti-Cancer Drugs;31(3) |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
dc.source | Scientia |
dc.subject | Tumors neuroendocrins - Prognosi |
dc.subject.mesh | Neuroendocrine Tumors |
dc.subject.mesh | Prognosis |
dc.title | Prognostic value of the neutrophil/lymphocyte ratio in enteropancreatic neuroendocrine tumors |
dc.type | info:eu-repo/semantics/article |
dc.identifier.doi | 10.1097/CAD.0000000000000909 |
dc.subject.decs | tumores neuroendocrinos |
dc.subject.decs | pronóstico |
dc.relation.publishversion | https://doi.org/10.1097/CAD.0000000000000909 |
dc.type.version | info:eu-repo/semantics/publishedVersion |
dc.audience | Professionals |
dc.contributor.organismes | Institut Català de la Salut |
dc.contributor.authoraffiliation | [Grenader T] Oncology Institute, Leumit Health Services, Jerusalem, Israel. [Pavel ME] Medizinische Klinik m. S. Hepatologie und Gastroenterologie, Charité University Medicine Berlin, Berlin, Germany. Department of Endocrinology, Friedrich Alexander University Erlangen-Nuernberg, Erlangen, Germany. [Ruszniewski PB] Department of Gastroenterology-Pancreatology, Beaujon Hospital, Clichy, France. [Ćwikła JB] Department of Radiology, University of Varmia and Masuria, Olsztyn, Poland. [Phan AT] Hematology, Oncology & Radiation Oncology, University of Texas Health Science Center at Tyler, Tyler, Texas, USA. [Raderer M] Department of Oncology, University Hospital, Vienna, Austria. [Capdevila J] Servei d’Oncologia Mèdica, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institute of Oncology (VHIO), Barcelona, Spain |
dc.identifier.pmid | 31977567 |
dc.identifier.wos | 000528817300003 |
dc.rights.accessrights | info:eu-repo/semantics/openAccess |